Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07107386 · ClinicalTrials.gov registry record

Temporal Investigation of Multimodal Elements

A clinical trial of Health, sponsored by Buck Institute for Research on Aging.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT07107386: Recruiting study of Health, sponsored by Buck Institute for Research on Aging.

NCT07107386 is a study of Health that is actively recruiting participants, run by Buck Institute for Research on Aging. The registered enrollment target is 120 participants, below the 3,267-participant average among 6 other Health trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07107386, a study of Health, is actively recruiting participants, sponsored by Buck Institute for Research on Aging.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

The TIME Study is a research project aiming to understand the body's natural rhythms. The goal is to see how daily and weekly changes in our bodies-from what's happening at a molecular level to data from wearable devices-are connected. What is the study about? This study is trying to create a detailed map of how a person's body changes over time. By looking at information from blood, urine, and other samples, as well as data from smartwatches and other devices, researchers want to learn how our bodies' natural cycles work in healthy older adults. The long-term goal is to use this knowledge to help develop more personalized healthcare in the future. Who can participate? The study is looking for healthy adults, age 55 or older, who have a smartphone and are able to travel to the Buck Institute in Novato, California, for study visits. Participants will be asked to: Attend weekly visits over 11 weeks to provide blood and other samples. Wear health-tracking devices like a smart ring and watch. Use a smartphone app to answer questions about their daily routines. Complete two "challenge" tests, including drinking a glucose solution and exercising on a stationary bicycle. Return for follow-up visits after 6 and 12 months. Are there any risks or benefits? Benefits: There are no direct health benefits for participants. However, the information gained will help scientists create better diagnostic tools and treatments for future generations. Risks: The main risks are minor discomfort from things like blood draws or skin irritation from the wearable devices. All personal information and data are kept private and secure.

Primary Outcome

Establish a publicly shareable reference dataset integrating blood-based proteomic, metabolomic, and lipidomic profiles with continuous digital health data and microbiome samples from healthy older adults over time, capturing daily, weekly, and perturbation-induced physiological dynamics.

Conditions Studied

Study Locations (1)

California

  • Buck Institute - Novato

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-06-15
Est. Completion 2028-06

What NCT07107386 shows while recruiting

NCT07107386 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 3,267-participant average among 6 other Health trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Health appearing as the primary indexed condition, and to 0 interventions.

NCT07107386 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07107386 about?

NCT07107386 is a clinical study titled "Temporal Investigation of Multimodal Elements". The TIME Study is a research project aiming to understand the body's natural rhythms. The goal is to see how daily and weekly changes in our bodies-from what's happening at a molecular level to data from wearable devices-are connected. What is the study about? This study is trying to create a detai...

What is the current status of trial NCT07107386?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-06-15. Estimated completion is 2028-06.

What conditions does trial NCT07107386 study?

This clinical trial studies the following conditions: Health.

Who is sponsoring clinical trial NCT07107386?

This trial is sponsored by Buck Institute for Research on Aging, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07107386 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07107386, the US trial registry maintained by the National Library of Medicine. NCT07107386 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.